Summit Therapeutics plc - Company & Market Research Reports

Summit Therapeutics is a biopharmaceutical company focussed on the development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. The company is developing Ezutromid, an utrophin modulator product candidate that is in Phase II clinical trials used for to treat Duchenne muscular dystrophy disease. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

  • Report
  • 79 Pages
From
Global Duchenne Muscular Dystrophy Therapeutics Market By Drug, By Therapeutic Approach Clinical Trial Assessment & Pipeline Analysis Outlook 2022 - Product Thumbnail Image

Global Duchenne Muscular Dystrophy Therapeutics Market By Drug, By Therapeutic Approach Clinical Trial Assessment & Pipeline Analysis Outlook 2022

  • Report
  • 100 Pages
From
Market Spotlight: Duchenne Muscular Dystrophy (DMD) - Product Thumbnail Image

Market Spotlight: Duchenne Muscular Dystrophy (DMD)

  • Report
  • 35 Pages
From
Global Duchenne Muscular Dystrophy Treatment Market Size - Segmented by Therapeutic Approach, Treatment Type, End User and Geography - Growth, Trends, and Forecast (2018 - 2023) - Product Thumbnail Image

Global Duchenne Muscular Dystrophy Treatment Market Size - Segmented by Therapeutic Approach, Treatment Type, End User and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • Report
  • 120 Pages
From
Gonorrhea R&D Pipeline Analysis Report, H2-2018 - Product Thumbnail Image

Gonorrhea R&D Pipeline Analysis Report, H2-2018

  • Report
  • 40 Pages
From
Duchenne Muscular Dystrophy - Pipeline Review, H2 2018 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 279 Pages
From
Duchenne Muscular Dystrophy - Pipeline Review, H1 2018 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Pipeline Review, H1 2018

  • Drug Pipelines
  • 305 Pages
From
Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea - Product Thumbnail Image

Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea

  • Report
  • 65 Pages
From
Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD): Competitive Landscape to 2026

  • Report
  • 49 Pages
From
OpportunityAnalyzer: Clostridium difficile Infections - Opportunity Analysis and Forecasts to 2026 - Product Thumbnail Image

OpportunityAnalyzer: Clostridium difficile Infections - Opportunity Analysis and Forecasts to 2026

  • Drug Pipelines
  • 281 Pages
From
Diarrhea and Constipation Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diarrhea and Constipation Drug Development Pipeline Review, 2018

  • Report
  • 93 Pages
From
Global Clostridium Difficile Treatment Market 2017-2021 - Product Thumbnail Image

Global Clostridium Difficile Treatment Market 2017-2021

  • Report
  • 70 Pages
From
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2018 - Product Thumbnail Image

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 202 Pages
From
Clostridium difficile Infections - Pipeline Review, H1 2017 - Product Thumbnail Image

Clostridium difficile Infections - Pipeline Review, H1 2017

  • Drug Pipelines
  • 188 Pages
From
Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Duchenne Muscular Dystrophy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 166 Pages
From
2018 Diarrhea Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Diarrhea Drug Development- Pipeline Analysis Report

  • Report
  • 70 Pages
From
2018 Trigeminal Neuralgia Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Trigeminal Neuralgia Drug Development- Pipeline Analysis Report

  • Report
  • 35 Pages
From
Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026  - Product Thumbnail Image

Antibacterial Drug Resistance: Market Landscape, Challenges and Upcoming Opportunities, 2016-2026

  • Report
  • 266 Pages
From
Alzheimer's Disease - Pipeline Review, H2 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2018

  • Drug Pipelines
  • 1333 Pages
From
Diarrhea - Pipeline Review, H2 2018 - Product Thumbnail Image

Diarrhea - Pipeline Review, H2 2018

  • Drug Pipelines
  • 153 Pages
From
Loading Indicator
adroll